Proportion of Direct Acting Oral Anticoagulants (DOACs) not prescribed as edoxaban by all Sub-ICB Locations

Why it matters: In January 2022 the NHS in England announced a national procurement programme for DOACs, which states:

The NHS England National Medicines Optimisation Opportunities for 2023/24 identify using best value direct-acting oral anticoagulants as an area for improvement.

Please note: measures also have a consistent way of visualising measures, where 'lower is better' and therefore in this case we show the proportion of DOACs which are NOT prescribed as edoxaban.

Description: Percentage DOACs items not prescribed as edoxaban


Tagged as: Cardiovascular system, Standard, Cost Saving, National medicines optimisation opportunities (or browse all measures)

Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.